First human test: Dual-Dose stem cells aim to heal stroke damage
NCT ID NCT04434768
Summary
This is a first-in-human safety study testing stem cells from donated umbilical cords in 10 patients who recently had a stroke. The main goal is to see if a new method of giving the cells—through both an artery and a vein—is safe. Researchers will also look for early signs that the treatment might help with recovery from stroke.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
China Medical University Hospital
Taichung, Non-US, 404, Taiwan
Conditions
Explore the condition pages connected to this study.